Rolke James has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a tax payment of 8521 shares of REVELATION BIOSCIENCES, INC. ($REVB) on February 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | REVELATION BIOSCIENCES, INC. | $REVB | Rolke James | Chief Executive Officer | F | Common Stock | 8521 | $1.86 | 224,853.0000 | 5,924,137 | 3.65% | 0.14% |
| Jan. 8, 2026 | REVELATION BIOSCIENCES, INC. | $REVB | Rolke James | Chief Executive Officer | A | Common Stock | 532829 | $0.90 | 1,334,149.0000 | 5,924,137 | 66.49% | 8.99% |
| Oct. 29, 2025 | REVELATION BIOSCIENCES, INC. | $REVB | Rolke James | Chief Executive Officer | A | Common Stock | 390614 | $1.28 | 410,706.0000 | 905,228 | 1944.13% | 43.15% |
| Feb. 11, 2025 | REVELATION BIOSCIENCES, INC. | $REVB | Rolke James | Chief Executive Officer | A | Common Stock | 30095 | $3.87 | 30,179.0000 | 0 | 9999.99% | 0.00% |